Director/PDMR Shareholding

RNS Number : 6448O

Dechra Pharmaceuticals PLC

13 June 2022

 

13 June 2022

Dechra^® Pharmaceuticals PLC

(Dechra or the Company)

Dechra was notified today of the marriage of Ian Page and Zoe Bamford, who is now classified as a person closely associated (PCA) with Ian under UK MAR.  Zoe is the beneficial owner of 34,367 shares and, therefore, Ian's interest in the Company, together with his PCA's, now totals 392,388 shares, which represents 0.36% of the current issued share capital.

For further information, please contact:

Dechra Pharmaceuticals PLC

Group Secretariat Office

Telephone: [phone]

Email: [e-mail]  

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com .

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

DSHGCGDLXXBDGDX